NY Insurer Made $100 Million While Denying Coverage to Teenager

By NTK Staff | 03.22.2017 @3:35pm

The teenager has Duchenne Muscular Dystrophy and was denied coverage for a drug that could slow the progression of his disease.

After reports that it had denied coverage to a teenager with a rare disease, a New York health insurer announced a significant increase in profits.

Excellus BlueCross BlueShield announced 2016 profit of nearly $100 million:

“Excellus BlueCross BlueShield made a profit of $99.5 million in 2016 and paid its top executive $2.09 million. The health insurer’s profit was more than 1.5 times greater than the $58 million it made in 2015.”

Excellus, which is a nonprofit, also announced that its CEO’s compensation increased to $2.09 million. According to data from the Department of Health and Human Services, Excellus increased premiums on the ACA exchanges by an average of 9.7 percent for 2017.

The announcement comes after a December 2016 report in which a teenager with a rare disease alleged discrimination against Excellus. The teenager has Duchenne Muscular Dystrophy and was denied coverage for a drug that could slow the progression of his disease.

In 2012, Excellus paid $1 million in fines for improperly denying claims for emergency room care.

Sign Up

for NTK updates every week.